A 32-year-old woman at 8 weeks gestation is diagnosed with severe depression and is currently not on any psychotropic medication. She has a history of two previous suicide attempts. Psychiatric evaluation confirms she is at high risk of self-harm if left untreated. What is the most appropriate next step in management?

Explanation

## Clinical Context The patient presents with severe depression at 8 weeks gestation with high suicide risk. The clinical dilemma is balancing the teratogenic risk of antidepressants against the significant maternal and fetal risks of untreated severe depression. ## Key Principle: Risk-Benefit Analysis **Key Point:** Untreated maternal depression and suicide risk pose greater harm to mother and fetus than most antidepressant exposures. SSRIs are the safest class of antidepressants in pregnancy. **High-Yield:** SSRIs safe in pregnancy: - **Sertraline** — minimal placental transfer, lowest teratogenic risk - **Paroxetine** — historically associated with cardiac defects (relative contraindication, but not absolute if other SSRIs unavailable) - **Fluoxetine** — extensive safety data; acceptable alternative - **Citalopram** — reasonable choice **Mnemonic: SSRI Safety in Pregnancy — "SAFE"** - **S**ertraline (first choice) - **A**ccept fluoxetine (extensive data) - **F**luoxetine (long track record) - **E**scitalopram (acceptable) ## Management Approach ```mermaid flowchart TD A[Severe depression in pregnancy]:::outcome --> B{Suicide risk present?}:::decision B -->|Yes, high risk| C[Initiate SSRI after informed consent]:::action B -->|No, mild-moderate| D[Psychotherapy + consider SSRI]:::action C --> E[Sertraline or fluoxetine preferred]:::action D --> F[Reassess at each trimester]:::action E --> G[Monitor for maternal/fetal complications]:::action G --> H[Continue through pregnancy if benefit outweighs risk]:::outcome ``` ## Why This Answer Is Correct The patient has high suicide risk; withholding treatment poses greater danger to mother and fetus than SSRI exposure. Sertraline and fluoxetine have the most robust safety data. Informed consent and shared decision-making are essential. ## Why Other Options Fail | Distractor | Why Wrong | |---|---| | Defer antidepressants until 2nd trimester | High suicide risk in 1st trimester is life-threatening; delaying treatment is dangerous and unethical | | Prescribe TCAs | TCAs have anticholinergic effects, weight gain, and cardiac arrhythmia risk; SSRIs are safer and more selective | | Recommend termination | Termination is not indicated for depression; SSRIs are safe enough to allow continuation of pregnancy with treatment | [cite:Harrison 21e Ch 297]